Your browser doesn't support javascript.
loading
Regulation, targets and functions of CHK.
Zhu, Shudong; Sun, Rong; Guo, Xialing; Bao, Yuanwu; Zhang, Dianzheng.
Afiliação
  • Zhu S; School of Medicine, Nantong University, Nantong, China.
  • Sun R; Argus Pharmaceuticals, Changsha, China.
  • Guo X; School of Medicine, Nantong University, Nantong, China.
  • Bao Y; Argus Pharmaceuticals, Changsha, China.
  • Zhang D; Triapex Biotechnology, Shanghai, China.
Front Cell Dev Biol ; 10: 1068952, 2022.
Article em En | MEDLINE | ID: mdl-36568988
ABSTRACT
Src family kinases (SFKs) play pivotal roles in multiple signaling pathways (Yeatman, 2004). SFK activity is inhibited by phosphorylation at its C-terminal tyrosine, by CSK (C-terminal Src kinase) and CHK (CSK-homologous kinase). CHK expression is restricted to normal hematopoietic cells, brain, and colon tissues. Downregulation of CHK in brain and colon tumors contributes to tumorigenicity in these tissues. CHK does not phosphorylate Src efficiently, however, in contrast to CSK, CHK inhibits Src kinase activity allosterically. Although the functions of CHK are still largely unknown, potential substrates of CHK including ß-synuclein, α-tubulin, α-spectrin, 14-3-3, and Hsp90 have been identified. CHK is regulated epigenetically via promoter methylation. As the unknown roles of CHK are beginning to be revealed, current knowledge of regulation, molecular targets and functions of CHK is summarized, and important topics for future CHK research are discussed.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Cell Dev Biol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Cell Dev Biol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
...